四川阿坝产野生大花红景天不同器官中红景天苷含量的比较

大花红景天[Rhodiola crenulata（Hook.f.et Thoms）H．Ohba]为药材红景天的基原植物,是珍稀的药食兼用天然植物资源之一[1-2]。红景天具有益气活血、通脉平喘、扶正固本的作用[1],主要含黄酮类、有机酸类、多糖类、苷类、香豆素类和挥发性成分等,其中包含的重要生物活性成分有红景天苷、红景天素、酪醇、二苯甲基六氢吡啶和超氧化物歧化酶（SOD）等,还含有维生素及人体必需的多种大量和微量元素,营养价值极高[3-5]。红景天具有抗疲劳、抗缺氧、强壮机体、抗心肌缺血、抗肿瘤和保护神经细胞等作用,红景天药材或其提取物已成为多种中成药、食品、饮料和化妆品的重要原料旧[6]。     

痢疾菌苗研究进展

痢疾是全世界范围内流行的肠道传染病。随着分子生物学技术的发展,迄今已构建了新一代预防痢疾的疫苗,其中包括:具有侵袭力和不具侵袭力的单价口服活菌苗候选株;它们与大肠杆菌、伤寒沙门氏菌和血清型不同的痢疾杆菌组成的双价和三价菌苗候选株;以及以脂多糖和核糖体为基础的不经胃肠的组分菌。猴体和人体试验证明它们安全有效。预计在未来的10年中,将会有一个或几个安全有效的痢疾疫苗投放市场。     

狭叶红景天幼苗对水分及遮阴的生长及生理生化响应

研究植物对水分和遮阴胁迫的响应及其生理机制对制定合理的栽培管理措施十分必要。以红景天属植物为研究对象,设置土壤含水量分别为田间持水量的80%(过湿水分)、70%(正常水分)、60%(轻度干旱)、40%(中度干旱)、20%(重度干旱)5个水分梯度;设置2个遮阴处理,以全光照(遮阴率为0)为对照、黑色遮阴网遮阴(遮阴率为85%),研究狭叶红景天生长及生理生化指标的变化特征。结果表明:在不同水分处理下,与对照相比,叶绿素含量、茎干重和茎重比(SMR)显著增加(P0.05),株高、总生物量、叶面积、叶干重、叶重比(LMR)、比叶面积(SLA)、叶面积比(LAR)和叶面积根干重比(LARMR)增加,根冠比和根重比(RMR)减少;随着干旱程度加剧,丙二醛(MDA)、脯氨酸(Pro)和可溶性糖(Ss)含量增加,超氧化物歧化酶(SOD)活性总体呈先增加后减小的趋势。在遮阴处理下,株高、SMR、SLA、LAR和LARMR显著增加(P0.05),叶绿素SPAD值和叶面积增加,总生物量、根干重、根冠比和LMR显著减少(P0.05),茎干重和叶干重减少,MDA含量显著增加,Pro含量略有下降,Ss含量减少。在水分胁迫下,狭叶红景天中度干旱时通过增加酶活性抵御伤害,重度干旱超过其阈值,SOD活性下降,植物体受到伤害,Ss可能是主要的渗透调节物质。在遮阴处理下,狭叶红景天通过增加SLA避免遮阴伤害。狭叶红景天在受到环境胁迫时会通过形态改变、调节MDA含量、抗氧化酶活性和渗透调节物质来保证自身正常的生长发育。     

江豚鼻道肌的解剖和构筑研究

江豚的鼻部肌共分为后外肌、前外肌、后内肌、前内肌和深肌5层,无间肌和大小内肌较退化,无对角膜肌。通过测定各肌的肌重、平均肌纤维长、平均肌小节长以及肌纤维角度,计算了各肌的生理横截面积,估计最大强直张力和肌鲜重对估计最大强直张力之比值等指标。鼻部肌各肌的相对肌纤维长度相似。各鼻部肌的肌纤维角度均为零。前部肌比后部肌具有较大的收缩速度和收缩位移优势,后部肌则具有较强的张力产生能力。着于额隆和唇部吻肌的张力产生能力很强。     

重组人GM—CSF／MCAF融合蛋白的变性,复性及纯化研究

人粒细胞巨噬细胞集落刺激因子(GM-CSF)和单核细胞趋化激活因子(MCAF)融合蛋白在大肠杆菌中高效表达后,表达产物以包涵体形式存在。包涵体经分离和洗涤后,探索了rhGM-CSF/MCAF变性和复性的合适条件。复性后的样品经Sephadex G-75凝胶过滤和CM-Sepharose FF离子交换两步层析,得到了具有生物学活性的SDS-PAGE纯的rhGM-CSF/MCAF。Western blot检测表明,纯化的rhGM-CSF/MCAF能分别与GM-CSF和MCAF抗体发生特异反应。     

大麦黄矮病毒运动蛋白是RNA沉默抑制因子

大麦黄矮病毒(barley yellow dwarf virus,BYDV)属黄症病毒科家族,其基因组包含6个开放阅读框(open reading frames,ORFs).将BYDV的6个基因分别克隆到pWEIMING101载体上,得到重组基因.电击转化农杆菌后,利用农杆菌瞬时表达方法渗透注射转GFP基因的本氏烟草16c植株的叶片,在长波长紫外灯下观察GFP的表达,并通过Northern blot证明所得现象.研究结果表明,BYDV的PAV株系ORF4编码的运动蛋白(movement protein,MP)是RNA沉默抑制因子,其表达可以抑制局部和系统RNA沉默.BYDV-MP与GFP的双链RNA(dsGFP)共表达后仍能抑制RNA沉默,荧光强度与叶片中GFP的mRNA和其沉默降解形成的siRNA的量有对应关系,其N端核定位序列对抑制局部基因沉默起主要作用,第5、6位氨基酸是抑制基因沉默的关键氨基酸.BYDV-MP单独渗透注射的部位均产生细胞死亡.     

志贺氏菌属弗氏2a染色体基因文库的构建

以λ噬菌体EMBL3作载体,用体外包装技术构建了志贺氏菌属弗氏2a染色体基因文库。该体外包装系统的包装效率达1.6×10~2pfu/μg DNA,重组噬菌体的产量达2×10~6pfu/μg DNA。对重组噬菌体进行了遗传分析,即分别对7个标记(leu,pro,his,arg,thr,purIaroA)作了测定。测得当噬菌体母液的效价为8.7×10~8pfu/ml时,带有以上标记的重组噬菌体的效价为5×10~4-8.2×10~5pfu/ml。这个令人满意的结果为尔后克隆志贺氏菌属弗氏2a染色体上的与群抗原3,4和型抗原Ⅱ有关的基因打下了基础。     

MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β

As a degenerative joint disease, osteoarthritis (OA) constitutes a major cause of disability that seriously affects the quality of life of a large population of people worldwide. However, effective treatment that can successfully reverse OA progression is lacking until now. The present study aimed to determine whether two small non-coding RNAs miR-29a and miR-140, which are significantly down-regulated in OA, can be applied together as potential therapeutic targets for OA treatment. MiRNA synergy score was used to screen the miRNA pairs that potentially synergistically regulate OA. An in vitro model of OA was established by treating murine chondrocytes with IL-1β. Transfection of miR-29a and miR-140 via plasmids was investigated on chondrocyte proliferation and expression of nine genes such as ADAMTS4, ADAMTS5, ACAN, COL2A1, COL10A1, MMP1, MMP3, MMP13 and TIMP metal-lopeptidase inhibitor 1 (TIMP1). Western blotting was used to determine the protein expression level of MMP13 and TIMP1, and ELISA was used to detect the content of type II collagen. Combined use of miR-29a and miR-140 successfully reversed the destructive effect of IL-1β on chondrocyte proliferation, and notably affected the MMP13 and TIMP1 gene expression that regulates extracellular matrix. Although co-transfection of miR-29a and miR-140 did not show a synergistic effect on MMP13 protein expression and type II collagen release, but both of them can significantly suppress the protein abundance of MMP13 and restore the type II collagen release in IL-1β treated chondrocytes. Compared with single miRNA transfection, cotransfection of both miRNAs exceedingly abrogated the suppressed the protein production of TIMP1 caused by IL-1β, thereby suggesting potent synergistic action. These results provided novel insights into the important function of miRNAs’ collaboration in OA pathological development. The reduced MMP13, and enhanced TIMP1 protein production and type II collagen release also implies that miR-29a and miR-140 combination treatment may be a possible treatment for OA.     

miR-155 inhibits oxidized low-density lipoprotein–induced apoptosis in different cell models by targeting the p85α/AKT pathway

Journal of Physiology and Biochemistry - The apoptosis of vascular endothelial cells (VECs), vascular smooth muscle cells (VSMCs), and macrophages directly causes the instability or rupture of...